Vor Biopharma Stock Shares Outstanding

VOR Stock  USD 1.01  0.03  2.88%   
Vor Biopharma fundamentals help investors to digest information that contributes to Vor Biopharma's financial success or failures. It also enables traders to predict the movement of Vor Stock. The fundamental analysis module provides a way to measure Vor Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vor Biopharma stock.
As of 12/11/2024, Common Stock Shares Outstanding is likely to drop to about 41 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Vor Biopharma Company Shares Outstanding Analysis

Vor Biopharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Vor Biopharma Shares Outstanding

    
  68.67 M  
Most of Vor Biopharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vor Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Vor Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for Vor Biopharma is extremely important. It helps to project a fair market value of Vor Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Vor Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vor Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vor Biopharma's interrelated accounts and indicators.
1.00.880.8-0.58-0.820.750.920.94-0.371.0-0.010.990.450.690.90.72
1.00.880.79-0.61-0.80.750.890.95-0.351.0-0.031.00.420.650.880.68
0.880.880.66-0.3-0.940.50.830.89-0.70.87-0.30.870.650.50.950.84
0.80.790.66-0.52-0.730.850.770.61-0.380.770.390.770.040.80.720.62
-0.58-0.61-0.3-0.520.15-0.6-0.32-0.52-0.17-0.63-0.22-0.640.27-0.36-0.220.09
-0.82-0.8-0.94-0.730.15-0.58-0.88-0.740.8-0.780.07-0.77-0.61-0.67-0.95-0.92
0.750.750.50.85-0.6-0.580.740.5-0.270.740.620.74-0.130.90.540.39
0.920.890.830.77-0.32-0.880.740.79-0.460.880.130.870.560.840.930.86
0.940.950.890.61-0.52-0.740.50.79-0.310.95-0.340.950.590.410.870.67
-0.37-0.35-0.7-0.38-0.170.8-0.27-0.46-0.31-0.340.12-0.33-0.42-0.36-0.59-0.66
1.01.00.870.77-0.63-0.780.740.880.95-0.34-0.041.00.420.640.870.66
-0.01-0.03-0.30.39-0.220.070.620.13-0.340.12-0.04-0.04-0.620.65-0.19-0.16
0.991.00.870.77-0.64-0.770.740.870.95-0.331.0-0.040.40.630.860.65
0.450.420.650.040.27-0.61-0.130.560.59-0.420.42-0.620.40.10.710.77
0.690.650.50.8-0.36-0.670.90.840.41-0.360.640.650.630.10.610.58
0.90.880.950.72-0.22-0.950.540.930.87-0.590.87-0.190.860.710.610.94
0.720.680.840.620.09-0.920.390.860.67-0.660.66-0.160.650.770.580.94
Click cells to compare fundamentals

Vor Shares Outstanding Historical Pattern

Today, most investors in Vor Biopharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Vor Biopharma's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Vor Biopharma shares outstanding as a starting point in their analysis.
   Vor Biopharma Shares Outstanding   
       Timeline  
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Vor Common Stock Shares Outstanding

Common Stock Shares Outstanding

41.03 Million

At this time, Vor Biopharma's Common Stock Shares Outstanding is relatively stable compared to the past year.
Based on the latest financial disclosure, Vor Biopharma has 68.67 M of shares currently outstending. This is 61.96% lower than that of the Biotechnology sector and 35.73% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 87.99% higher than that of the company.

Vor Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vor Biopharma's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vor Biopharma could also be used in its relative valuation, which is a method of valuing Vor Biopharma by comparing valuation metrics of similar companies.
Vor Biopharma is currently under evaluation in shares outstanding category among its peers.

Vor Fundamentals

About Vor Biopharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Vor Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vor Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vor Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Vor Biopharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vor Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Vor Stock

  0.69FLGC Flora Growth CorpPairCorr
  0.66GNFT GenfitPairCorr
  0.6IMAB I MabPairCorr
The ability to find closely correlated positions to Vor Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vor Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vor Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vor Biopharma to buy it.
The correlation of Vor Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vor Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vor Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vor Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Vor Stock Analysis

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.